News

MEDIA CONTACT

Exactech’s Vitamin E Acetabular Polyethylene Liner for Hip Replacement Gains FDA 510(k) Clearance

Gainesville, Fla. (March 19, 2018) – Exactech, a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip announced today it has received…

View Story

Exactech Equinoxe Shoulder System Stemless Shoulder. A bone conserving prosthesis designed for anatomic total shoulder arthroplasty.

Exactech Receives 510(k) Clearance for Equinoxe® Stemless Shoulder

Gainesville, Fla. (March 12, 2018) – Exactech, a leading developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip announced today it has…

View Story

Exactech Knee System, Ankle, Shoulder Stem, Hip Stem and Computer-Assisted Surgery Technology Headline at Booth #5023, AAOS 2018 Annual Meeting

GAINESVILLE, Fla. (March 6, 2018) – Exactech, a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip announced today its lineup of products to…

View Story

Orthopaedic Industry Veteran Jeffrey R. Binder Joins Bill Petty, MD, as Co-Executive Chairman of Exactech; Daniel Hann Joins Exactech as Sr. Vice President of Business Development

GAINESVILLE, Fla. (March 5, 2018) – Exactech, a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip announced today the appointment of Jeffrey R.…

View Story

Exactech Announces Completion of Merger with TPG Capital

Gainesville, Fla. (Feb. 14, 2018) – Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce…

View Story

Exactech Shareholders Approve Merger Agreement with TPG Capital

Gainesville, Fla. (Feb. 13, 2018) – Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at…

View Story

Exactech Announces Successful First Surgery with Vantage® Total Ankle Mobile Bearing System

GAINESVILLE, Fla. (Dec. 7, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery…

View Story

Exactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 per share. Merger with TPG Capital Now Valued at $737 Million.

Gainesville, Fla. (December 4, 2017) – Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has…

View Story

Exactech Announces Successful First Revision Knee Replacement Surgery with Truliant® Instrumentation

System to Debut at the AAHKS Annual Meeting, Booth #908 in Dallas GAINESVILLE, Fla. (Nov. 1, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products…

View Story

Exactech Q3 Revenue $61.4 Million; Q3 Net Income $2.9 Million; Diluted EPS $0.20

GAINESVILLE, Fla. (Oct. 30, 2017) — Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that…

View Story

Media contact

Nancy Walsh
Senior Marketing Communications Director
media@exac.com
352-377-1140

Courtney Adkins
Marketing Communications Director
media@exac.com
352-377-1140

News

Exactech’s Vitamin E Acetabular Polyethylene Liner for Hip Replacement Gains FDA 510(k) Clearance

Exactech Receives 510(k) Clearance for Equinoxe® Stemless Shoulder

Exactech Knee System, Ankle, Shoulder Stem, Hip Stem and Computer-Assisted Surgery Technology Headline at Booth #5023, AAOS 2018 Annual Meeting

Orthopaedic Industry Veteran Jeffrey R. Binder Joins Bill Petty, MD, as Co-Executive Chairman of Exactech; Daniel Hann Joins Exactech as Sr. Vice President of Business Development

Exactech Announces Completion of Merger with TPG Capital

Exactech Shareholders Approve Merger Agreement with TPG Capital

Exactech Announces Successful First Surgery with Vantage® Total Ankle Mobile Bearing System

Exactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 per share. Merger with TPG Capital Now Valued at $737 Million.

Exactech Announces Successful First Revision Knee Replacement Surgery with Truliant® Instrumentation

Exactech Q3 Revenue $61.4 Million; Q3 Net Income $2.9 Million; Diluted EPS $0.20

Media contact

Company Info

Compliance

Learn More

News

Sign up to receive email alerts

Media contact

Company Info

Compliance

Learn More